FM DECEMBER 2018 ISSUE - digital edition
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
news updates<br />
ICMR releases new<br />
antimicrobial stewardship<br />
guidelines<br />
The Indian Council of Medical<br />
Research (ICMR) has released<br />
Antimicrobial Stewardship Guidelines<br />
documents for hospital administrators<br />
and clinicians, recently.<br />
The guideline is intended to provide<br />
directions to Indian hospitals to set up<br />
structure and processes of antimicrobial<br />
stewardship programmes (AMSP).<br />
There is an urgent need to improve<br />
antibiotic use in hospitals, which can<br />
be achieved through implementation<br />
of good AMS programmes. AMS<br />
programmes have been found helpful<br />
in improving the quality of patient<br />
care and safety through increasing<br />
the frequency of correct therapy and<br />
prophylaxis, reducing treatment failures<br />
and increased infection cure rates,<br />
according to an ICMR statement.<br />
Implementation of an effective<br />
AMSP requires a multidisciplinary<br />
approach involving a variety of experts.<br />
Most of the hospitals in India lack<br />
structure and process of AMSP.<br />
Recognizing the importance to<br />
create AMSP structures in healthcare<br />
institutions in the country, ICMR has<br />
initiated AMSP activities by developing<br />
AMSP curriculum, conducting workshops<br />
and developing AMSP research projects.<br />
The ‘National Health Policy’ (2017),<br />
addresses antimicrobial resistance as<br />
one of the key issues and prioritises<br />
development of guidelines regarding<br />
antibiotic use, limiting the over-thecounter<br />
use of antibiotics, restricting the<br />
use of antibiotics as growth promoters<br />
in livestock, and pharmaco-vigilance<br />
including prescription audit inclusive<br />
of antibiotic usage in the hospital and<br />
community.<br />
Nephroplus<br />
acquires<br />
DaVita Care<br />
NephroPlus, a dialysis care<br />
network, has acquired<br />
DaVita Care India, part of<br />
DaVita Inc., a Fortune 500<br />
company.<br />
Under the terms of the<br />
agreement, NephroPlus will<br />
acquire DaVita Care India’s<br />
network of 22 centres which<br />
serve more than 1,700 dialysis<br />
patients nationwide.<br />
The acquisition will boost<br />
Nephroplus’ servicing<br />
capacity as a dialysis centre<br />
network and will have a<br />
presence in 18 states of India<br />
with 176 centers across 97<br />
cities.<br />
DaVita Care (India) Pvt.<br />
Ltd. owns and operates a<br />
network of dialysis and<br />
kidney care centers that<br />
provide care for acute and<br />
end-stage renal disease<br />
patients in India. The company<br />
offers dialysis services,<br />
including in-center and<br />
home hemodialysis,<br />
peritoneal dialysis, and<br />
AV fistula and AV graft<br />
procedures and allied services<br />
that include psychological<br />
counselling and diet and<br />
nutrition advice.<br />
TCS backs<br />
research on<br />
SIDS<br />
Tata Consultancy Services<br />
(TCS) has donated 5,000<br />
8 / FUTURE MEDICINE / <strong>DECEMBER</strong> <strong>2018</strong>